NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today that Dr. Gur Roshwalb, Chief …
Celsus Therapeutics Provides Year End 2013 Financial Results and Corporate Highlights
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, today announced its financial results and …
Celsus Therapeutics Provides Update on MRX-6 from FDA Pre-IND Meeting
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today that it held a …
[Read more...] about Celsus Therapeutics Provides Update on MRX-6 from FDA Pre-IND Meeting
Celsus Therapeutics Plc to Present at the 2014 BIO CEO & Investor Conference
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today that Dr. Gur Roshwalb, Chief …
[Read more...] about Celsus Therapeutics Plc to Present at the 2014 BIO CEO & Investor Conference
Celsus Therapeutics Announces the Closing of $9.2 Million Public Offering and Full Exercise of Underwriters Option to Purchase Additional ADSs
NEW YORK AND LONDON Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, announced today the closing of its previously …
